Companies in the oncology sector developing innovative solutions and technologies.
Explore 303 recently funded oncology companies with verified founder contact information and fundraising data.
Autem Therapeutics is an oncology therapeutic and bioelectric technology company which provides cancer care.
Liminatus Pharma is a immuno‑oncology company offering CD47‑blockade antibody solutions to prevent anemia and thrombocytopenia.
Incanthera develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific
Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.
Alnair Therapeutics is a preclinical stage precision oncology platform focusing on developing innovative approaches to treat difficult.
Medicenna is a clinical stage, privately held, immuno-oncology company.
Siren Biotechnology focuses on combining AAV gene therapy with cytokine immunotherapy to develop innovative treatments for cancer.
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
xCures is a SaaS platform that aggregates, organizes and structures EMRs providing multimodal data across all diseases.
Thalia Therapeutics is a drug reformulation company.
DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.
ChemoTech is an innovator in gentle cancer treatment and effective pain management.
Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering.
Replicate Bioscience develops self-replicating RNA therapeutics and vaccines delivering immunity at lower doses across multiple diseases.
One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.
Spot BioSystems is a bioengineering firm that specializes in extracellular vesicle mediated mRNA therapy
Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.
HekaBio is an ecosystem for a healthcare development platform that provides therapeutic treatments in oncology and ophthalmology.
Elucida Oncology develops targeted C'Dot Drug Conjugates (CDCs) for patients with primary solid tumor and metastatic cancer.
Flamingo Therapeutics is pioneering RNA-targeted therapies for oncology.
Vysioneer is an oncology AI company that enables pharma and clinicians to find the right treatment for tumors.
Zumutor Biologics develops immuno-oncology therapies that harness the body's innate immune system to treat cancer.
AI-driven engineering of the proteome via RNA splicing control
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.
The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 303 oncology companies tracked in the VCBacked database.
Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked